Skip to main content
OpenTrials

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,580 public trials 828 recruiting studies
Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Recruiting

68Ga-BCMA PET/CT in Multiple Myeloma

NCT07319897

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease, +17 more
Locations
  • Beijing An Zhen Hospital of the Capital University of Medical Sciences Beijing, Beijing Municipality, China
  • Beijing Tsinghua Changgung Hospital Beijing, Beijing Municipality, China
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • the Second Hospital of Hebei Medical University Shijiazhuang, Hebei, China
View Trial Details
Recruiting

A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery

NCT05156983

Conditions
Cardiovascular Diseases, Coagulation Disorder, Hematologic Diseases, +4 more
Locations
  • University of Arkansas Medical Sciences Arkansas City, Arkansas, United States
  • University of California Davis Health System Sacramento, California, United States
  • Denver Metro Orthopedics, P.C. Englewood, Colorado, United States
  • University of Florida Gainesville, Florida, United States
View all 64 locations
View Trial Details
Recruiting

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

NCT04566328

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 649 locations
View Trial Details
Recruiting

A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)

NCT07231952

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations
  • Dana Farber Cancer Institute (Data Collection and Specimen Analysis) Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center (Data Collection Only) Boston, Massachusetts, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memoral Sloan Kettering Monmouth Middletown, New Jersey, United States
View Trial Details
Recruiting

A Phase 2 Study to Assess STP938 (Dencatistat) as a Monotherapy in Adults With High Risk Essential Thrombocythaemia - The VECTRA Trial

NCT06786234

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Hôpital de la Milétrie, CHU Poitiers, New Aquitaine, France
  • CHU Brest Brest, France
  • Institut Paoli-Calmettes Marseille, France
  • CHU Nantes Nantes, France
View all 14 locations
View Trial Details

Related conditions